,i #aafth ,,congress #b;d ,session ,h4 ,r4 #giga ,,in ,,the ,,house ,,of ,,representatives ,august #g1 #bjbj,mr4 ,krishnamoorthi 7for himself1 ,mr4 ,connolly1 ,ms4 ,tlaib1 ,ms4 ,pressley1 ,ms4 ,porter1 ,mr4 ,khanna1 and ,mr4 ,de,saulnier7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to direct the ,food and ,drug ,administration to solicit and consider the recommendations of the ,vaccines and ,related ,biological ,products ,advisory ,committee before taking certain actions with respect to ,,covid-#ai vaccines1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,expeditious ,vaccine ,advice with ,legitimate1 ,unbiased1 ,apolitical1 and ,technical ,expertise ,act or the ,,evaluate ,act4 #b4 ,required consideration of advisory committee recommendations 7a7 ,vaccine licensure or authorization ,before licensing or authorizing any vaccine for ,,covid-#ai or ,,sars-,co,v-#b infection 7in this section referred to as a ,,covid-#ai vaccine71 the ,commissioner of ,food and ,drugs shall-- 7#a7 solicit recommendations from the ,vaccines and ,related ,biological ,products ,advisory ,committee on whether the available data are adequate to support the safety and effectiveness of the ,,covid-#ai vaccine and whether additional studies to further evaluate safety and effectiveness should be required before or after licensing or authorization2 7#b7 receive such recommendations at an open meeting2 7#c7 give public notice of such meeting at least #c business days in advance of the meeting2 and 7#d7 publicly document how such recommendations were considered when licensing or authorizing the ,,covid-#ai vaccine4 7b7 ,minor or technical changes ,subsection 7a7 does not apply-- 7#a7 to minor or technical changes to a license or authorization that is in effect2 or 7#b7 in cases involving a change to a license or authorization if the ,commissioner of ,food and ,drugs publishes a determination that the change is not substantial and a meeting under subsection 7a7 would not be appropriate4 7c7 ,provision of information 7#a7 ,in general ,in connection with a meeting of the ,vaccines and ,related ,biological ,products ,advisory ,committee convened for purposes of subsection 7a71 the ,commissioner of ,food and ,drugs shall-- 7,a7 provide to the ,advisory ,committee1 at least #c business days prior to the meeting1 any data1 summaries of data1 briefing documents1 and other information to be presented at the meeting by the ,commissioner and the sponsor of the ,,covid-#ai vaccine1 and make reasonable efforts to provide any additional data1 summaries of data1 or information requested by the ,advisory ,committee before the meeting2 and 7,b7 promptly make available on the ,food and ,drug ,administration's website minutes1 audiovisual recordings1 transcripts1 data1 summaries of data1 briefing documents1 and other information or documents made available to or prepared for or by the ,advisory ,committee4 7#b7 ,exception ,the ,commissioner need not make available minutes1 audiovisual recordings1 transcripts1 data1 summaries of data1 briefing documents1 and other information or documents pursuant to paragraph 7#a77;,b7 if the ,commissioner-- 7,a7 determines that the minutes1 audiovisual recordings1 transcripts1 data1 summaries of data1 briefing documents1 or other information or documents should be withheld from disclosure in accordance with section #eeb;b7c7 of title #e1 ,united ,states ,code2 and 7,b7 promptly makes available on the public website of the ,food and ,drug ,administration a written explanation of the reasons for not disclosing the minutes1 audiovisual recordings1 transcripts1 data1 summaries of data1 briefing documents1 or other information or documents4